Keywords: plethora, psd502, ph, ii, enrollment, complete, uk-based

Plethora's PSD502 Ph II enrollment complete

Article | 19 September 2005

Print This

UK-based pharmaceutical developer Plethora Solutions says that it has completed enrollment of patients for a Phase II clinical study of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in